Drugs / AZD7760
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06749457 | Dec 2024 → Apr 2027 expected | staphylococcus aureus infection | AstraZeneca | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD7760 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06749457 ↗ |
| Route | Intravenous | “single intravenous infusion” NCT06749457 ↗ |